Hepatocellular carcinoma and antidepressants: a nationwide population-based study.
about
Selective serotonin reuptake inhibitors and the risk of hepatocellular carcinoma in hepatitis B virus-infected patients.Case-Control Study Examining the Association between Selective Serotonin Reuptake Inhibitors Use and Hepatocellular Carcinoma.Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVES.Antidepressant medication use and nasopharyngeal cancer risk: a nationwide population-based study.
P2860
Hepatocellular carcinoma and antidepressants: a nationwide population-based study.
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Hepatocellular carcinoma and antidepressants: a nationwide population-based study.
@ast
Hepatocellular carcinoma and antidepressants: a nationwide population-based study.
@en
type
label
Hepatocellular carcinoma and antidepressants: a nationwide population-based study.
@ast
Hepatocellular carcinoma and antidepressants: a nationwide population-based study.
@en
prefLabel
Hepatocellular carcinoma and antidepressants: a nationwide population-based study.
@ast
Hepatocellular carcinoma and antidepressants: a nationwide population-based study.
@en
P2093
P2860
P356
P1433
P1476
Hepatocellular carcinoma and antidepressants: a nationwide population-based study
@en
P2093
Chiao-Fan Lin
Hsiang-Lin Chan
Hsin-Yi Liang
Kuo-You Huang
Roger S McIntyre
Vincent Chin-Hung Chen
Wei-Che Chiu
Yi-Hsuan Hsieh
P2860
P304
30464-30470
P356
10.18632/ONCOTARGET.12826
P407
P50
P577
2017-05-01T00:00:00Z